Reneuron (RENE.L) is a stem cell research company whose focus is on therapies targeting areas of poorly met medical need, including peripheral arterial disease, stroke, and retinal diseases. RENE is currently testing the effects of neural stem cells on spines for neuroregeneration, and is testing the use of fetal stem cells on stroke patients.
A UK company, used as a scientific comparable due to status of trials and disease state.
November 7, 2011
RegMed Daily, Mid-Day, 11/7/11, directionless, down Monday
October 31, 2011
RegMed Daily Dialogue, 10/31/11, relinquishing some … of October gains and pains
October 28, 2011
RegMed Daily, Mid-Day, 10/28/11, more risks and reverses ahead, stocks on the fence
October 27, 2011
RegMed Daily, Mid-Day, 10/27/11, free at last, free at last of EU, let their dust settle
October 26, 2011
RegMed Daily, Mid-Day, 10/26/11, any daily gain at risk by next day
October 25, 2011
RegMed Daily, Mid-Day, 10/25/11, will the EU issues wash up on our shores, no
October 24, 2011
RegMed Daily, Mid-Day, 10/24/11, defining the next 2 months' market, stocks flat line to slow recovery
October 19, 2011
RegMed Daily, Mid-Day, 10/19/11, my newest relief, EU markets close at 11:30am, EST each day
October 18, 2011
RegMed Daily, Mid-Day, 10/18/11, defining expectation, call me tomorrow, then the next day and so forth
October 14, 2011
RegMed Daily, Mid-Day, 10/14/11, perception is reality in this market
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.